Jeanette H. W. Leusen^1,2, Arthur J. Verhoeven¹ and Dirk Roos^1,3

¹ Central Laboratory of the Netherlands Red Cross Blood Transfusion Service and Laboratory for Experimental and Clinical Immunology, University of Amsterdam, Plesmanlaan 125, 1066 CX Amsterdam, The Netherlands.

²Department of Pediatrics, Emma's Children Hospital, Academic Medical Center, Amsterdam, The Netherlands.

Received 04/15/96; Accepted 05/05/96; On-line 07/01/96

1. S. J. Weiss: Tissue destruction by neutrophils. N Engl J Med 320, 365-76 (1989)

2. A. J. Verhoeven, B.G.J.M. Bolscher & D. Roos: The superoxidegenerating enzyme in phagocytes: physiology, protein composition, and mechanism of activation.In: Membrane Lipid Oxidation. VigoPelfrey, C. editor. CRC press, Boston, pp. 42-59 (1991)

3. R. A. Clark: The human neutrophil respiratory burst oxidase. J Infect Dis 161, 1140-7 (1990)

4. L. T. Williams, R. Snyderman, M. C. Pike, & R. J. Lefkowitz: Specific receptor sites for chemotactic peptides on human polymorphonuclear leukocytes. Proc Natl Acad Sci USA 74, 1204-8 (1977)

5. J. E. Lehmeyer, R. Snyderman & R. B. Johnston: Stimulation of neutrophil oxidative metabolism by chemotactic peptides: influence of calcium ion concentration and cytochalasin B and comparison with stimulation by phorbol myristate acetate. Blood 54, 35-45 (1979)

6. F. Rossi: The O₂^-forming NADPH oxidase of the phagocytes: nature, mechanisms of activation and function. Biochim Biophys Acta 853, 65-89 (1986)

7. A. R. Cross & O. T. Jones. Enzymic mechanisms of superoxide production. Biochim Biophys Acta 1057, 281-98 (1991)

8. F. Morel, J. Doussière & P. V. Vignais: The superoxidegenerating oxidase of phagocytic cells. Physiological, molecular and pathological aspects. Eur J Biochem 201, 523-46 (1991)

9. M. Baggiolini, F. Boulay, J. A. Badwey & J. T. Curnutte: Activation of neutrophil leukocytes: Chemoattractant receptors and respiratory burst. FASEB J 7, 1004-10 (1993)

10. P. G. Quie, J. G. White, P. G. Holmes & R. A. Good: In vitro bactericidal capacity of human polymorphonuclear leucocytes: diminished activity in chronic granulomatous disease of childhood. J Clin Invest 46, 668-79 (1967)

11. A. W. Segal: Chronic granulomatous disease. Clin.Exp.Allergy 21 Suppl 1, 195-8 (1991)

12. C. B. Forrest, J. R. Forehand, R. A. Axtell, R. L. Roberts & R. B. Johnston: Clinical features and current management of chronic granulomatous disease. Hematol Oncol Clin North Am 2, 253-67 (1988)

13. R. M. Smith & J. T. Curnutte: Molecular basis of chronic granulomatous disease. Blood 77, 673-86 (1991)

14. L. M. Kunkel, A. P. Monaco, W. Middlesworth, H. D. Ochs & S. A. Latt: Specific cloning of DNA fragments absent from the DNA of a male patient with an X chromosome deletion. Proc Natl Acad Sci USA 82, 4778-82 (1985)

15. M. C. Dinauer, E. A. Pierce, G. A. Bruns, J. T. Curnutte & S. H. Orkin: Human neutrophil cytochrome b light chain (p22phox). Gene structure, chromosomal location, and mutations in cytochromenegative autosomal recessive chronic granulomatous disease. J Clin Invest 86, 1729-37 (1990)

16. B. D. Volpp, W. M. Nauseef & R. A. Clark: Two cytosolic neutrophil oxidase components absent in autosomal chronic granulomatous disease. Science 242, 1295-7 (1988)

17. H. Nunoi, D. Rotrosen, J. I. Gallin & H. L. Malech: Two forms of autosomal chronic granulomatous disease lack distinct neutrophil cytosol factors. Science 242, 1298-301 (1988)

18. K. J. Lomax, T. L. Leto, H. Nunoi, J. I. Gallin & H. L. Malech: Recombinant 47kilodalton cytosol factor restores NADPH oxidase in chronic granulomatous disease [erratum appeared in Science 246, 987 (1989)

]. Science 245, 409-12 (1989)

19. B. D. Volpp, W. M. Nauseef, J. E. Donelson, D. R. Moser & R. A. Clark: Cloning of the cDNA and functional expression of the 47kilodalton cytosolic component of human neutrophil respiratory burst oxidase [erratum appeared in Proc.Natl.Acad.Sci.U.S.A. 1989; 86, 9563]. Proc Natl Acad Sci U S A 86, 7195-9 (1990)

20. T. L. Leto, K. J. Lomax, B. D. Volpp, H. Nunoi, J. M. Sechler, W. M. Nauseef, R. A. Clark, J. I. Gallin & H. L. Malech: Cloning of a 67kD neutrophil oxidase factor with similarity to a noncatalytic region of p60csrc. Science 248, 727-30 (1990)

21. D. R. Ambruso, B. G. J. M. Bolscher, P. M. Stokman, A. J. Verhoeven & D. Roos: Assembly and activation of the NADPH:O₂ oxidoreductase in human neutrophils after stimulation with phorbol myristate acetate [erratum appeared in J.Biol.Chem. 265, 19370-19371 (1990) J Biol Chem 265, 924-30 (1990)

22. R. A. Clark, B. D. Volpp, K. G. Leidal & W. M. Nauseef: Two cytosolic components of the human neutrophil respiratory burst oxidase translocate to the plasma membrane during cell activation. J Clin Invest 85, 714-21 (1990)

23. A. W. Segal: Absence of both cytochrome b_-245 subunits from neutrophils in X-linked chronic granulomatous disease. Nature 326, 88-91 (1987)

24. C. A. Parkos, R. A. Allen, C. G. Cochrane & A. J. Jesaitis: Purified cytochrome b from human plasma membrane is comprised of two polypeptides with relative molecular weights of 91,000 and 22,000. J Clin Invest 80, 732-42 (1987)

25. A. W. Segal & O. T. Jones: Subcellular distribution and some properties of the cytochrome b component of the microbicidal oxidase system of human neutrophils. Biochem J 182, 181-8 (1979)

26. A. R. Cross, T. G. Jones, A. M. Harper & A. W. Segal: Oxidationreduction properties of the cytochrome b found in the plasmamembrane fraction of human neutrophils. Biochem J 194, 599-606 (1981)

27. A. W. Segal, I. West, F. Wientjes, J. H. Nugent, A. J. Chavan, B. Haley, R. C. Garcia, H. Rosen & Scrace: Cytochrome b_-245 is a flavocytochrome containing FAD and the NADPHbinding site of the microbicidal oxidase of phagocytes. Biochem J 284, 781-8 (1992)

28. D. Rotrosen, C. L. Yeung, T. L. Leto, H. L. Malech & C. H. Kwong: Cytochrome b₅₅₈: the flavinbinding component of the phagocyte NADPH oxidase. Science 256, 1459-62 (1992)

29. H. Sumimoto, N. Sakamoto, M. Nozaki, Y. Sakaki, K. Takeshige & S. Minakami: Cytochrome b₅₅₈, a component of the phagocyte NADPH oxidase, is a flavoprotein. Biochem Biophys Res Commun 186, 1368-75 (1992)

30. M. T. Quinn, M. L. Mullen & A. J. Jesaitis: Human neutrophil cytochrome b contains multiple hemes. Evidence for heme associated with both subunits. J Biol Chem 267, 7303-9 (1992)

31. A. W. Segal: The electron transport chain of the microbicidal oxidase of phagocytic cells and its involvement in the molecular pathology of chronic granulomatous disease. J Clin Invest 83, 1785-93 (1989)

32. O. W. Bjerrum & N. Borregaard: Dual granule localization of the dormant NADPH oxidase and cytochrome b559 in human neutrophils [erratum appeared in Eur. J.Haematol. 8, 270 (1989)]. Eur J Haematol 43, 67-77 (1989)

33. L. A. Ginsel, J. J. Onderwater, J. A. Fransen, A. J. Verhoeven & D. Roos: Localization of the lowMr subunit of cytochrome b₅₅₈ in human blood phagocytes by immunoelectron microscopy. Blood 76, 2105-16 (1990)

34. J. Calafat, T. W. Kuijpers, H. Janssen, N. Borregaard, A. J. Verhoeven & D. Roos: Evidence for small intracellular vesicles in human blood phagocytes containing cytochrome b₅₅₈ and the adhesion molecule CD11b/CD18. Blood 81, 3122-9 (1993)

35. N. Borregaard, J. M. Heiple, E. R. Simons & R. A. Clark: Subcellular localization of the b-cytochrome component of the human neutrophil microbicidal oxidase: translocation during activation. J Cell Biol 97, 52-61 (1983)

36. B. Royer-Pokora, L. M. Kunkel, A. P. Monaco, S. C. Goff, P. E. Newburger, R. L. Baehner, F. S. Cole, J. T. Curnutte & S. H. Orkin: Cloning the gene for an inherited human disorderchronic granulomatous diseaseon the basis of its chromosomal location. Nature 322, 32-8 (1986)

37. C. G. Teahan, P. Rowe, P. Parker, N. Totty & A. W. Segal: The Xlinked chronic granulamotous disease gene codes for the beta chain of cytochrome b_-245. Nature 327, 720-1 (1987)

38. C. A. Parkos, M. C. Dinauer, L. W. Walker, R. A. Allen, A. J. Jesaitis & S. H. Orkin: Primary structure and unique expression of the 22kilodalton light chain of human neutrophil cytochrome b. Proc Natl Acad Sci U S A 85, 3319-23 (1988)

39. M. C. Dinauer, S. H. Orkin, R. Brown, A. J. Jesaitis & C. A. Parkos: The glycoprotein encoded by the Xlinked chronic granulomatous disease locus is a component of the neutrophil cytochrome b complex. Nature 327, 717-20 (1987)

40. S. Imajoh Ohmi, K. Tokita, H. Ochiai, M. Nakamura & S. Kanegasaki: Topology of cytochrome b₅₅₈ in neutrophil membrane analyzed by antipeptide antibodies and proteolysis. J Biol Chem 267, 180-4 (1992)

41. D. Roos, M. de Boer, N. Borregaard, O. W. Bjerrum, N. H. Valerius, R. A. Seger, T. Muhlebach, B. H. Belohradsky & R. S. Weening: Chronic granulomatous disease with partial deficiency of cytochrome b₅₅₈ and incomplete respiratory burst: variants of the X-linked, cytochrome b₅₅₈-negative form of the disease. J Leukoc Biol 51, 164-71 (1992)

42. M. C. Dinauer, J. T. Curnutte, H. Rosen & S. H. Orkin: A missense mutation in the neutrophil cytochrome b heavy chain in cytochromepositive Xlinked chronic granulomatous disease. J Clin Invest 84, 2012-6 (1989)

43. B. L. Schapiro, P. E. Newburger, M. S. Klempner & M. C. Dinauer: Chronic granulomatous disease presenting in a 69yearold man. N Engl J Med 325, 1786-90 (1991)

44. J. H. W. Leusen, M. de Boer, B. G. J. M., Bolscher, P. M. Hilarius, R. S. Weening, H. D. Ochs, D. Roos & A. J. Verhoeven: A point mutation in gp91phox of cytochrome b₅₅₈ of the human NADPH oxidase leading to defective translocation of the cytosolic proteins p47-phox and p67-phox. J Clin Invest 93, 2120-6 (1994)

45. M. de Boer, A. de Klein, J. P. Hossle, R. Seger, L. Corbeel, R. S. Weening & D. Roos: Cytochrome b₅₅₈-negative, autosomal recessive chronic granulomatous disease: two new mutations in the cytochrome b₅₅₈ light chain of the NADPH oxidase (p22-phox)

. Am J Hum Genet 51, 1127-35 (1992)

46. M. C. Dinauer, E. A. Pierce, R. W. Erickson, T. J. Muhlebach, H. Messner, S. H. Orkin, R. A. Seger & J. T. Curnutte: Point mutation in the cytoplasmic domain of the neutrophil p22-phox cytochrome b subunit is associated with a nonfunctional NADPH oxidase and chronic granulomatous disease. Proc Natl Acad Sci U S A 88, 11231-5 (1991)

47. C. A. Koch, D. Anderson, M. F. Moran, C. Ellis & T. Pawson: SH2 and SH3 domains: elements that control interactions of cytoplasmic signaling proteins. Science 252, 668-74 (1991)

48. A. Musacchio, T. Gibson, V. P. Lehto & M. Saraste: SH3: an abundant protein domain in search of a function. FEBS Lett 307, 55-61 (1992)

49. R. Ren, B. J. Mayer, P. Cicchetti & D. Baltimore: Identification of a tenamino acid prolinerich SH3 binding site. Science 259, 1157-61 (1993)

50. J. H. W. Leusen, B. G. J. M. Bolscher, P. M. Hilarius, R. S. Weening, W. Kaulfersch, R. A. Seger, D. Roos & A. J. Verhoeven: ¹⁵⁶Pro--->Gln substitution in the light chain of cytochrome b₅₅₈ of the human NADPH oxidase (p22phox)

leads to defective translocation of the cytosolic proteins p47-phox and p67-phox. J Exp Med 180, 2329-34 (1994)

51. C. A. Parkos, M. C. Dinauer, A. J. Jesaitis, S. H. Orkin & J. T. Curnutte: Absence of both the 91kD and 22kD subunits of human neutrophil cytochrome b in two genetic forms of chronic granulomatous disease. Blood 73, 1416-20 (1989)

52. A. J. Verhoeven, B. G. J. M. Bolscher, L. J. Meerhof, R. van Zwieten, J. Keijer, R. S. Weening & D. Roos: Characterization of two monoclonal antibodies against cytochrome b₅₅₈ of human neutrophils. Blood 73, 1686-94 (1989)

53. C. D. Porter, M. H. Parkar, A. J. Verhoeven, R. J. Levinsky, M. K. L. Collins & C. Kinnon: p22-phox-Deficient chronic granulomatous disease: Reconstitution by retrovirus-mediated expression and identification of a boisynthetic intermediate of gp91-phox. Blood 84, 2767-75 (1994)

54. M. T. Quinn, C. A. Parkos, L. Walker, S. H. Orkin, M. C. Dinauer & A. J. Jesaitis: Association of a Rasrelated protein with cytochrome b of human neutrophils. Nature 342, 198-200 (1989)

55. M. T. Quinn, M. L. Mullen, A. J. Jesaitis & J. G. Linner: Subcellular distribution of the Rap1A protein in human neutrophils: colocalization and cotranslocation with cytochrome b₅₅₉. Blood 79, 1563-73 (1992)

56. L. A. Quilliam, H. Mueller, B. P. Bohl, V. Prossnitz, L. A. Sklar, C. J. Der & G. M. Bokoch: Rap1A is a substrate for cyclic AMPdependent protein kinase in human neutrophils [erratum appeared in J.Immunol. 147, 3660 (1991)

]. J Immunol 147, 1628-35 (1991)

57. G. M. Bokoch, L. A. Quilliam, B. P. Bohl, A. J. Jesaitis & M. T. Quinn: Inhibition of Rap1A binding to cytochrome b₅₅₈ of NADPH oxidase by phosphorylation of Rap1A. Science 254, 1794-6 (1991)

58. R. A. Clark, H. L. Malech, J. I. Gallin, H. Nunoi, B. D. Volpp, D. W. Pearson, W. M. Nauseef & J. T. Curnutte: Genetic variants of chronic granulomatous disease: prevalence of deficiencies of two cytosolic components of the NADPH oxidase system. N Engl J Med 321, 647-52 (1989)

59. A. W. Segal, P. G. Heyworth, S. Cockcroft & M. M. Barrowman: Stimulated neutrophils from patients with autososomal recessive chronic granulomatous disease fail to phosphorylate a Mr-44,000 protein. Nature 316, 547-9 (1985)

60. P. C. Andrews & B. M. Babior: Phosphorylation of cytosolic proteins by resting and activated human neutrophils. Blood 64, 883-90 (1984)

61. T. Hayakawa, K. Suzuki, S. Suzuki, P. C. Andrews & B. M. Babior: A possible role for protein phosphorylation in the activation of the respiratory burst in human neutrophils. Evidence from studies with cells from patients with chronic granulomatous disease. J Biol Chem 261, 9109-15 (1986)

62. P. G. Heyworth, C. F. Shrimpton & A. W. Segal: Localization of the 47 kDa phosphoprotein involved in the respiratoryburst NADPH oxidase of phagocytic cells. Biochem J 260, 243-8 (1989)

63. N. Okamura, J. T. Curnutte, R. L. Roberts & B. M. Babior: Relationship of protein phosphorylation to the activation of the respiratory burst in human neutrophils. Defects in the phosphorylation of a group of closely related 48kDa proteins in two forms of chronic granulomatous disease. J Biol Chem 263, 6777-82 (1988)

64. N. Okamura, S. E. Malawista, R. L. Roberts, H. Rosen, H. D. Ochs, B. M. Babior & J. T. Curnutte: Phosphorylation of the oxidaserelated 48K phosphoprotein family in the unusual autosomal cytochromenegative and Xlinked cytochromepositive types of chronic granulomatous disease. Blood 72, 811-6 (1988)

65. U. Francke, C. L. Hsieh, B. E. Foellmer, K. J. Lomax, H. L. Malech & T. L. Leto: Genes for two autosomal recessive forms of chronic granulomatous disease assigned to 1q25 (NCF2)

and 7q11.23 (NCF1). Am J Hum Genet 47, 483-92 (1990)

66. J. T. Curnutte, P. J. Scott & L. A. Mayo: Cytosolic components of the respiratory burst oxidase: resolution of four components, two of which are missing in complementing types of chronic granulomatous disease. Proc Natl Acad Sci U S A 86, 825-9 (1989)

67. B. G. J. M. Bolscher, R. van Zwieten, I. M. Kramer, R. S. Weening, A. J. Verhoeven & D. Roos: A phosphoprotein of Mr 47,000, defective in autosomal chronic granulomatous disease, copurifies with one of two soluble components required for NADPH:O2 oxidoreductase activity in human neutrophils. J Clin Invest 83, 757-63 (1989)

68. C. G. Teahan, N. Totty, C. M. Casimir & A. W. Segal: Purification of the 47 kDa phosphoprotein associated with the NADPH oxidase of human neutrophils. Biochem J 267, 485-9 (1990)

69. P. G. Heyworth, J. T. Curnutte, W. M. Nauseef, B. D. Volpp, D. W. Pearson, H. Rosen & R. A. Clark: Neutrophil nicotinamide adenine dinucleotide phosphate (reduced form) oxidase assembly: Translocation of p47-phox and p67-phox requires interaction between p47-phox and cytochrome b₅₅₈. J Clin Invest 87, 352-6 (1991)

70. M. E. Kleinberg, D. Mital, D. Rotrosen & H. L. Malech: Characterization of a phagocyte cytochrome b₅₅₈ 91-kilodalton subunit functional domain: identification of peptide sequence and amino acids essential for activity. Biochemistry 31, 2686-90 (1992)

71. D. J. Uhlinger, K. L. Taylor & J. D. Lambeth: p67-phox enhances the binding of p47-phox to the human neutrophil respiratory burst oxidase complex. J Biol Chem 269, 22095-8 (1994)

72. F. B. Wientjes, J. J. Hsuan, N. F. Totty & A. W. Segal: p40-phox, a third cytosolic component of the activation complex of the NADPH oxidase to contain src homology 3 domains. Biochem J 296, 557-61 (1993)

73. S. Tsunawaki, H. Mizunari, M. Nagata, O. Tatsuzawa & T. Kuratsuji: A novel cytosolic component, p40-phox, of respiratory burst oxidase associates with p67-phox and is absent in patients with chronic granulomatous disease who lack p67-phox. Biochem Biophys Res Commun 199, 1378-87 (1994)

74. U. G. Knaus, P. G. Heyworth, T. Evans, J. T. Curnutte & G. M. Bokoch: Regulation of phagocyte oxygen radical production by the GTPbinding protein Rac 2. Science 254, 1512-5 (1991)

75. A. Abo, E. Pick, A. Hall, N. Totty, C. G. Teahan & A. W. Segal: Activation of the NADPH oxidase involves the small GTPbinding protein p21rac1. Nature 353, 668-70 (1991)

76. A. Abo & E. Pick: Purification and charac-terization of a third cytosolic component of the superoxidegenerating NADPH oxidase of macrophages. J Biol Chem 266, 23577-85 (1991)

77. U. G. Knaus, P. G. Heyworth, B. T. Kinsella, J. T. Curnutte, & G. M. Bokoch: Purification and characterization of Rac 2. A cytosolic GTPbinding protein that regulates human neutrophil NADPH oxidase. J Biol Chem 267, 23575-82 (1992)

78. O. Dorseuil, A. Vazquez, P. Lang, J. Bertoglio, G. Gacon & G. Leca: Inhibition of superoxide production in B lymphocytes by rac antisense oligonucleotides. J Biol Chem 267, 20540-2 (1992)

79. S. Dusi, M. Donini & F. Rossi: Mechanisms of NADPH oxidase activation in human neutrophils: p67phox is required for the translocation of rac 1 but not of rac 2 from cytosol to the membranes. Biochem J 308, 991-4 (1995)

80. T. Mizuno, K. Kaibuchi, S. Ando, T. Musha, K. Hiraoka, K. Takaishi, M. Asada, H. Nunoi, I. Matsuda & Y. Takai: Regulation of the superoxidegenerating NADPH oxidase by a small GTPbinding protein and its stimulatory and inhibitory GDP/GTP exchange proteins. J Biol Chem 267, 10215-8 (1992)

81. R. A. Heyneman & R. E. Vercauteren: Activation of a NADPH oxidase from horse polymorphonuclear leukocytes in a cellfree system. J Leukocyte Biol 36, 751-9 (1984)

82. Y. Bromberg & E. Pick: Activation of NADPHdependent superoxide production in a cellfree system by sodium dodecyl sulfate. J Biol Chem 260, 13539-45 (1985)

83. J. T. Curnutte: Activation of human neutrophil nicotinamide adenine dinucleotide phosphate, reduced (trisphosphopyridine nucleotide, reduced) oxidase by arachidonic acid in a cellfree system. J Clin Invest 75, 1740-3 (1985)

84. T. G. Gabig, D. English, L. P. Akard & M. J. Schell: Regulation of neutrophil NADPH oxidase activation in a cellfree system by guanine nucleotides and fluoride. Evidence for participation of a pertussis and cholera toxininsensitive G protein. J Biol Chem 262, 1685-90 (1987)

85. R. A. Clark, K. G. Leidal, D. W. Pearson & W. M. Nauseef: NADPH oxidase of human neutrophils. Subcellular localization and characterization of an arachidonateactivatable superoxidegenerating system. J Biol Chem 262, 4065-74 (1987)

86. S. E. Caldwell, C. E. McCall, C. L. Hendricks, P. A. Leone, D. A. Bass, D.A. & L. C. McPhail: Coregulation of NADPH oxidase activation and phosphorylation of a 48kD protein(s)

by a cytosolic factor defective in autosomal recessive chronic granulomatous disease. J Clin Invest 81, 1485-96 (1988)

87. J. Doussière, M. C. Pilloud & P. V. Vignais: Activation of bovine neutrophil oxidase in a cell free system. GTPdependent formation of a complex between a cytosolic factor and a membrane protein. Biochem Biophys Res Commun 152, 993-1001 (1988)

88. B. G. J. M. Bolscher, S. W. Denis, A. J. Verhoeven & D. Roos: The activity of one soluble component of the cellfree NADPH:O2 oxidoreductase of human neutrophils depends on guanosine 5'O(3thio)

triphosphate. J Biol Chem 265, 15782-7 (1990)

89. A. Abo, A. Boyhan, I. West, A. Thrasher & A. W. Segal: Reconstitution of neutrophil NADPH oxidase activity in the cellfree system by four components: p67phox, p47phox, p21rac1 and cytochrome b245. J Biol Chem 267, 16767-70 (1992)

90. V. Koshkin & E. Pick: Generation of superoxide by purified and relipidated cytochrome b559 in the absence of cytosolic activators. FEBS Lett 327, 57-62 (1993)

91. V. Koshkin & E. Pick: Superoxide production by cytochrome b559. Mechanism of cytosolindependent activation. FEBS Lett 338, 285-9 (1994)

92. J. K. Hurst, T. M. Loehr, J. T. Curnutte & H. Rosen: Resonance Raman and electron paramagnetic resonance structural investigations of neutrophil cytochrome b₅₅₈. J Biol Chem 266, 1627-34 (1991)

93. A. R. Cross, P. G. Heyworth, J. Rae & J. T. Curnutte: A variant Xlinked chronic granulomatous disease patient (X91+)

with partially functional cytochrome b. J Biol Chem 270, 8194-200 (1995)

94. A. R. Cross, J. Rae & J. T. Curnutte: Cytochrome b245 of the neutrophil superoxidegenerating system contains two nonidentical hemes. J Biol Chem 270, 17075-7 (1995)

95. H. Azuma, H. Oomi, K. Sasaki, I. Kawabata, T. Sakaino, S. Koyano, T. Suzutani, H. Nunoi & A. Okuno: A new mutation in exon 12 of the gp91phox gene leading to cytochrome bpositive Xlinked chronic granulomatous disease. Blood 85, 3274-7 (1995)

96. W. R. Taylor, D. T. Jones & A. W. Segal: A structural model for the nucleotide binding domains of the flavocytochrome b245 betachain. Protein Sci 2, 1675-85 (1993)

97. A. J. Verhoeven, J. H. W. Leusen, G. C. R. Kessels, P. M. Hilarius, D. B. De Bont & R. M. Liskamp: Inhibition of neutrophil NADPH oxidase assembly by a myristoylated pseudosubstrate of protein kinase C. J Biol Chem 268, 18593-8 (1993)

98. A. R. Cross, J. L. Yarchover & J. T. Curnutte: The superoxidegenerating system of human neutrophils possesses a novel diaphorase activity. Evidence for distinct regulation of electron flow within NADPH oxidase by p67phox and p47phox. J Biol Chem 269, 21448-54 (1994)

99. A. R. Cross & J. T. Curnutte: The cytosolic activating factors p47phox and p67phox have distinct roles in the regulation of electron flow in NADPH oxidase. J Biol Chem 270, 6543-8 (1995)

100. A. Nakanishi, S. Imajoh-Ohmi, T. Fujinawa, H. Kikuchi & S. Kanegasaki: Direct evidence for interaction between COOH-terminal regions of cytochrome b₅₅₈ subunits and cytosolic 47-kDa protein during activation of an O2--generating system in neutrophils. J Biol Chem 267, 19072-4 (1992)

101. F. R. DeLeo, L. Yu, J. B. Burritt, L. R. Loetterle, C. W. Bond, A. J. Jesaitis & M. T. Quinn: Mapping sites of interaction of p47-phox and flavocytochrome b with random sequence peptide phage display libraries. Proc Natl Acad Sci USA 92, 7110-4 (1995)

102. F. R. DeLeo, W. M. Nauseef, A. J. Jesaitis, J. B. Burritt, R. A. Clark & M. T. Quinn: A domain of p47phox that interacts with human neutrophil flavocytochrome b₅₅₈. J Biol Chem 270, 26246-51 (1995)

103. G. Joseph, Y. Gorzalczany, V. Koshkin & E. Pick: Inhibition of NADPH oxidase activation by synthetic peptides mapping within the carboxyl-terminal domain of small GTP-binding proteins. Lack of amino acid sequence specificity and importance of polybasic motif. J Biol Chem 269, 29024-31 (1994)

104. J. W. Park, M. Ma, J. M. Ruedi, R. M. Smith & B. M. Babior: The cytosolic components of the respiratory burst oxidase exist as a M(r)

approximately 240,000 complex that acquires a membranebinding site during activation of the oxidase in a cellfree system. J Biol Chem 267, 17327-32 (1992)

105. J. W. Park, J. El Benna, K. E. Scott, B. L. Christensen, S. J. Chanock & B. M. Babior: Isolation of a complex of respiratory burst oxidase components from resting neutrophil cytosol. Biochemistry 33, 2907-11 (1994)

106. S. S. Iyer, D. W. Pearson, W. M. Nauseef & R. A. Clark: Evidence for a readily dissociable complex of p47phox and p67phox in cytosol of unstimulated human neutrophils. J Biol Chem 269, 22405-11 (1994)

107. T. Pawson: SH2 and SH3 domains in signal transduction. Adv Cancer Res 64, 87-110 (1994)

108. J. H. W. Leusen, K. Fluiter, P. M. Hilarius, D. Roos, A. J. Verhoeven & B. G. J. M. Bolscher: Interactions between the cytosolic components p47phox and p67phox of the human neutrophil NADPH oxidase that are not required for activation in the cellfree system. J Biol Chem 270, 11216-21 (1995)

109. D. J. Uhlinger & D. K. Perry: A carboxyterminal peptide from p47phox is a substrate for phosphorylation by protein kinase C and by a neutrophil protein kinase. Biochem Biophys Res Commun 187, 940-8 (1992)

110. P. Finan, Y. Shimizu, I. Gout, J. Hsuan, O. Truong, C. Butcher, P. Bennett, M. D. Waterfield & S. Kellie: An SH3 domain and prolinerich sequence mediate an interaction between two components of the phagocyte NADPH oxidase complex. J Biol Chem 269, 13752-5 (1994)

111. T. L. Leto, A. G. Adams & I. de Mendez: Assembly of the phagocyte NADPH oxidase: binding of Src homology 3 domains to prolinerich targets. Proc Natl Acad Sci U S A 91, 10650-4 (1994)

112. H. Sumimoto, Y. Kage, H. Nunoi, H. Sasaki, T. Nose, Y. Fukumaki, M. Ohno, S. Minakami & K. Takeshige: Role of Src homology 3 domains in assembly and activation of the phagocyte NADPH oxidase. Proc Natl Acad Sci U S A 91, 5345-9 (1994)

113. I. de Mendez, M. C. Garrett, A. G. Adams & T. L. Leto: Role of p67phox SH3 domains in assembly of the NADPH oxidase system. J Biol Chem 269, 16326-32 (1994)

114. A. Fuchs, M.- C. Dagher & P. V. Vignais: Mapping the domains of interaction of p40phox with both p47phox and p67phox of the neutrophil oxidase complex using the two hybrid system. J Biol Chem 270, 5695-7 (1995)

115. IJ. M. Kramer, A. J. Verhoeven, R. L. van der Bend, R. S. Weening & D. Roos: Purified protein kinase C phosphorylates a 47kDa protein in control neutrophil cytoplasts but not in neutrophil cytoplasts from patients with the autosomal form of chronic granulomatous disease. J Biol Chem 263, 2352-7 (1988)

116. W. M. Nauseef, B. D. Volpp, S. McCormick, K. G. Leidal & R. A. Clark: Assembly of the neutrophil respiratory burst oxidase. Protein kinase C promotes cytoskeletal and membrane association of cytosolic oxidase components. J Biol Chem 266, 5911-7 (1991)

117. J. T. Curnutte, R. W. Erickson, J. Ding & J. A. Badwey: Reciprocal interactions between protein kinase C and components of the NADPH oxidase complex may regulate superoxide production by neutrophils stimulated with a phorbol ester. J Biol Chem 269, 10813-9 (1994)

118. IJ. M. Kramer, R. L. van der Bend, A. T. J. Tool, W. J. van Blitterswijk, D. Roos & A. J. Verhoeven: 1Ohexadecyl2Omethylglycerol, a novel inhibitor of protein kinase C, inhibits the respiratory burst in human neutrophils. J Biol Chem 10, 5876-84 (1989)

119. J. M. Robinson, P. G. Heyworth & J. A. Badway: Utility of staurosporine in uncovering differences in the signal transduction pathways for superoxide production in neutrophils. Biochim Biophys Acta 1055, 55-62 (1990)

120. G. C. Kessels, K. H. Krause & A. J. Verhoeven: Protein kinase C activity is not involved in Nformylmethionylleucylphenylalanineinduced phospholipase D activation in human neutrophils, but is essential for concomitant NADPH oxidase activation: studies with a staurosporine analogue with improved selectivity for protein kinase C. Biochem J 292, 781-5 (1993)

121. D. Rotrosen & T. L. Leto: Phosphorylation of neutrophil 47kDa cytosolic factor. Translocation to membrane is associated with distinct phosphorylation events. J Biol Chem 265, 19910-5 (1990)

122. J. El Benna, L. P. Faustm & B. M. Babior: The phosphorylation of the respiratory burst oxidase component p47phox during neutrophil activation. Phosphorylation of sites recognized by protein kinase C and by prolinedirected kinases. J Biol Chem 269, 23431-6 (1994)

123. P. G. Heyworth & J. A. Badwey: Continuous phosphorylation of both the 47 and the 49 kDa proteins occurs during superoxide production by neutrophils. Biochim Biophys Acta 1052, 299-305 (1990)

124. J. Ding & J. A. Badwey: Effects of antagonists of protein phosphatases on superoxide release by neutrophils. J Biol Chem 267, 6442-8 (1992)

125. J. M. Robinson & J. A. Badwey: The NADPH oxidase complex of phagocytic leukocytes: A biochemical and cytochemical view. Histochemistry 103, 163-80 (1995)

126. D. J. Lu, A. Takai, T. L. Leto & S. Grinstein: Modulation of neutrophil activation by okadaic acid, a protein phosphatase inhibitor. Am J Physiol 262, C39-49 (1992)

127. J. Ding & J. A. Badwey: Stimulation of neutrophils with a chemoattractant activates several novel protein kinases that can catalyze the phosphorylation of peptides derived from the 47kDa protein component of the phagocyte oxidase and myristoylated alaninerich C kinase substrate. J Biol Chem 268, 17326-33 (1993)

128. S. Grinstein, W. Furuya, J. R. Butler & J. Tseng: Receptormediated activation of multiple serine/threonine kinases in human leukocytes. J Biol Chem 268, 20223-31 (1993)

129. J. Ding & J. A. Badwey: Wortmannin and 1butanol block activation of a novel family of protein kinases in neutrophils. FEBS Lett 348, 149-52 (1994)

130. F. A. Gonzales, D. L. Raden & R. J. Davis: Identification of substrate recognition determinants for human ERK1 and ERK2 protein kinases. J Biol Chem 266, 22159-63 (1991)

131. P. J. Kennely & E. G. Krebs: Consensus sequences as substrate specificity determinants for protein kinases and protein phosphatases. J Biol Chem 266, 15555-8 (1991)

132. S. H. Jackson, H. L. Malech, C. A. Kozak, K. J. Lomax, J. I. Gallin & S. M. Holland: Cloning and functional expression of the mouse homologue of p47phox. Immunogenetics 39, 272-5 (1994)

133. L. P. Faust, J. El Benna, B. M. Babior & S. J. Chanock: The phosphorylation targets of p47phox, a subunit of the respiratory burst oxidase. Functions of the individual target serines as evaluated by sitedirected mutagenesis. J Clin Invest 96, 1499-505 (1995)

134. C. H. Kwong, H. L. Malech, D. Rotrosen & J. L Leto: Regulation of the human neutrophil NADPH oxidase by rhorelated Gproteins. Biochemistry 32, 5711-7 (1993)

135. P. G. Heyworth, U. G. Knaus, X. Xu, D. J. Uhlinger, L. Conroy, G. M. Bokoch & J. T. Curnutte: Requirement for posttranslational processing of Rac GTPbinding proteins for activation of human neutrophil NADPH oxidase. Mol Biol Cell 4, 261-9 (1993)

136. S. Ando, K. Kaibuchi, T. Sasaki, K. Hiraoka, T. Nishiyama, T. Mizuno, M. Asada, H. Nunoi, I. Matsuda, Y. Matsuura, P. Polakis, F. McCormick & Y. Takai: Posttranslational processing of rac p21s is important both for their interaction with the GDP/GTP exchange proteins and for their activation of NADPH oxidase. J Biol Chem 36, 25709-13 (1995)

137. F. E. Maly, L. A. Quilliam, O. Dorseuil, C. J. Der & G. M. Bokoch: Activated or dominant inhibitory mutants of Rap1A decrease the oxidative burst of EpsteinBarr virustransformed human B lymphocytes. J Biol Chem 269, 18743-6 (1994)

138. T. G. Gabig, C. D. Crean, P. L. Mantel & R. Rosli: Function of wildtype or mutant Rac2 and Rap1a GTPases in differentiated HL60 cell NADPH oxidase activation. Blood 85, 804-11 (1995)

139. T. H. Chuang, B. P. Bohl & G. M. Bokoch: Biologically active lipids are regulators of Rac.GDI complexation. J Biol Chem 268, 26206-11 (1993)

140. N. Bourmeyster, M. -J. Stasia, J. Garin, J. Gagon, P. Boquet & P. V. Vignais: Copurification of Rho protein and the RhoGDP dissociation inhibitor from bovine neutrophil cytosol. Effect of phosphoinositides on Rho ADPribosylation by the C3 exoenzyme of Clostridium botulinium. Biochemistry 31, 12863-9 (1992)

141. P. T. Hawkins, A. Eguinoa, R. -G. Qiu, D. Stokoe, F. T. Cooke, R. Walters, S. Wennström, L. ClaessonWelsh, T. Evans, M. Symons & L. Stephens: PDGF stimulates an increase in GTPRac via activation of phosphoinositide 3kinase. Curr Biol 5, 393-403 (1995)

142. B. Dewald, M. Thelen & M. Baggiolini: Two transduction sequences are necessary for neutrophil activation by receptor agonists. J Biol Chem 263, 16179-84 (1988)

143. T. Okada, L. Sakuma, Y. Fukui, O. Hazeki & M. Ui: Blockage of chemotactic peptideinduced stimulation of neutrophils by wortmannin as a result of selective inhibition of phosphatidylinositol 3kinase. J Biol Chem 269, 3563-7 (1994)

144. D. Diekmann, A. Abo, C. Johnston, A. W. Segal & A. Hall: Interaction of Rac with p67phox and regulation of phagocytic NADPH oxidase activity. Science 265, 531-3 (1994)

145. E. Prigmore, S. Ahmed, A. Best, R. Kozma, E. Manser, A. W. Segal & L. Lim: A 68kDa kinase and NADPH oxidase component p67phox are targets for Cdc42Hs and Rac1 in neutrophils. J Biol Chem 270, 10717-22 (1995)

146. U. G. Knaus, S. Morris, H. - J. Dong, J. Chernoff & G. M. Bokoch: Regulation of human leukocyte p21activated kinases through G proteincoupled receptors. Science 269, 221-3 (1995)

147. J. R. White, P. H. Naccache & R. I. Sha'afi: Stimulation by chemotactic factor of actin association with the cytoskeleton in rabbit neutrophils. J Biol Chem 258, 14041-7 (1983)

148. M. T. Quinn, T. Evans, L. R. Loetterle, A. J. Jesaitis & G. M. Bokoch: Translocation of Rac correlates with NADPH oxidase activation. Evidence for equimolar translocation of oxidase components. J Biol Chem 268, 20983-7 (1993)

149. J. El Benna, J. M. Ruedi & B. M. Babior: Cytosolic guanine nucleotidebinding protein Rac2 operates in vivo as a component of the neutrophil respiratory burst oxidase. Transfer of Rac2 and the cytosolic oxidase components p47phox and p67phox to the submembranous actin cytoskeleton during oxidase activation. J Biol Chem 269, 6729-34 (1994)

150. V. Le Cabec, H. Möhn, G. Gacon & I. MaridonneauParini: The small GTPbinding protein rac is not recruited to the plasma membrane upon NADPH oxidase activation in human neutrophils. Biochem Biophys Res Commun 198, 1216-24 (1994)

151. P. G. Heyworth, B. P. Bohl, G. M. Bokoch & J. T. Curnutte: Rac translocates independently of the neutrophil NADPH oxidase components p47phox and p67phox. Evidence for its interaction with flavo-cytochrome b₅₅₈. J Biol Chem 269, 30749-52 (1994)

152. O. Dorseuil, M. T. Quinn & G. M. Bokoch: Dissociation of rac translocation from p47phox/p67phox movements in human neutrophils by tyrosine kinase inhibitors. J Leukoc Biol 58, 108-13 (1995)

153. A. J. Ridley, H. F. Paterson, C. L. Johnston, D. Diekmann & A. Hall: The small GTPbinding protein rac regulates growth factorinduced membrane ruffling. Cell 70, 401-10 (1992)

154. L. P. Akard, D. English & T. G. Gabig: Rapid deactivation of NADPH oxidase in neutrophils: continuous replacement by newly activated enzyme sustains the respiratory burst. Blood 72, 322-7 (1988)

155. M. Y. Park, S. Imajoh Ohmi, H. Nunoi & S. Kanegasaki: Peptides corresponding to the region adjacent to His94 in the small subunit of cytochrome b₅₅₈ inhibit superoxide generation in a cellfree system from human neutrophils. Biochem Biophys Res Commun 204, 924-9 (1994)

156. D. Tisch, Y. Sharoni, M. Danilenko & I. Aviram: The assembly of neutrophil NADPH oxidase: effect of mastoparan and its synthetic analogues. Biochem J 310, 715-9 (1995)

157. P. A. Karplus, M. J. Daniels & J. R. Herriott: Atomic structure of ferredoxinNADP+ reductase: prototype for a structurally novel flavoenzyme family. Science 251, 60-6 (1991)

158. P. Kraulis: A program to produce both detailed and schematic plots of protein structures. J Appl Cryst 24, 946-50 (1991)